The Artificial Intelligence in Breast Imaging Market was valued at USD 492.14 million in 2024 and is projected to reach USD 1,624.62 million by 2032, growing at a compound annual growth rate (CAGR) of 16.1% during the forecast period 2025–2032. This strong growth trajectory reflects the accelerating adoption of artificial intelligence across breast imaging workflows as healthcare systems worldwide prioritize early detection, diagnostic accuracy, and operational efficiency in response to the rising global burden of breast cancer.
Artificial intelligence is increasingly transforming breast imaging by enhancing screening accuracy, reducing false positives, and significantly easing radiologists’ workloads. Clinical studies indicate that AI-assisted mammography can reduce recall rates by nearly 20% while lowering reading workloads by approximately 33%, without compromising diagnostic sensitivity. Advanced deep learning and machine learning algorithms are now capable of analyzing vast volumes of mammographic data, identifying subtle patterns that may be missed by traditional imaging approaches. As a result, AI-powered breast imaging solutions are becoming indispensable tools for screening, diagnosis, disease monitoring, and data management across hospitals and diagnostic centers.
Get free Sample Report@ https://www.snsinsider.com/sample-request/4488
The growing prevalence of breast cancer remains a key factor driving market expansion. According to global health estimates, breast cancer accounted for 684,996 deaths worldwide in 2020, making it the leading cancer among women. In the United States alone, approximately 297,790 new invasive breast cancer cases and 55,720 new ductal carcinoma in situ (DCIS) cases were projected in 2023, with nearly 43,700 deaths reported. This alarming rise in incidence has intensified the demand for accurate, scalable, and early diagnostic solutions. AI-enabled breast imaging systems are gaining traction as they deliver higher diagnostic precision, reduce false positives, and support earlier detection compared to conventional imaging modalities, ultimately improving patient outcomes and optimizing clinical workflows.
Technological advancements in artificial intelligence are further accelerating the evolution of breast imaging. Modern AI platforms leverage sophisticated deep learning architectures that continuously learn from large datasets, improving predictive performance over time. These innovations address long-standing challenges in mammography, including missed detections and unnecessary follow-ups, while enabling more personalized and data-driven care pathways. As healthcare providers face increasing screening volumes and a shortage of specialized radiologists, AI is emerging as a critical enabler of efficiency and diagnostic consistency.
Despite its promising outlook, the Artificial Intelligence in Breast Imaging Market faces certain restraints. High implementation costs, complex integration with existing imaging infrastructure, regulatory approval requirements, and data security concerns continue to pose challenges, particularly for smaller healthcare facilities. Additionally, the need for clinician training and workflow adaptation may slow adoption in some regions. However, ongoing technological refinement, growing clinical validation, and supportive regulatory frameworks are expected to gradually mitigate these barriers.
From a segmentation perspective, software dominated the market with approximately 58% share in 2024, driven by the widespread adoption of AI algorithms that power image analysis, lesion detection, and risk assessment. Software solutions play a central role in processing large datasets with high accuracy, enabling real-time decision support for radiologists. In terms of imaging modality, screening accounted for around 42% of market share, reflecting the global emphasis on early detection and preventive care. AI-powered screening tools are increasingly integrated into mammography programs to enhance accuracy and streamline diagnostic workflows.
Regionally, North America led the market with about 32% share in 2024, supported by advanced healthcare infrastructure, strong R&D investments, and early adoption of AI technologies. The presence of major industry players and continuous innovation in AI-enabled mammography systems have reinforced the region’s leadership. Meanwhile, Asia Pacific emerged as the second-fastest-growing region, capturing nearly 29% share, fueled by rising healthcare expenditure, improving diagnostic infrastructure, and growing awareness of breast cancer across emerging economies.
Leading companies operating in the Artificial Intelligence in Breast Imaging Market include GE Healthcare, Hologic, Siemens Healthineers, Fujifilm Holdings Corporation, Philips Healthcare, iCAD Inc., CureMetrix, Google Health, Canon Medical Systems, and Samsung Medison, among others. These players are actively investing in AI-driven innovations, strategic collaborations, and product launches to strengthen their market presence and expand clinical adoption.
As the global healthcare landscape continues to embrace digital transformation, artificial intelligence is set to play a pivotal role in redefining breast imaging. With its ability to enhance diagnostic accuracy, reduce clinician burden, and support early cancer detection, the Artificial Intelligence in Breast Imaging Market is poised for sustained growth through 2032, offering significant opportunities for technology providers, healthcare institutions, and patients worldwide.
Other Trending Reports
Wearable Drug Delivery Devices Market
Biopharmaceutical Excipients Market Growth
Knee Replacement Market Growth
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Rohan Jadhav – Principal Consultant
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: [email protected]
